JAK2 and essential thrombocythemia: In addition, mutations in the thrombopoietin receptor MPL [11], such as MPLW515L, or in the chaperone protein calreticulin (CALR) were identified in ET and MF, which converge on activation of JAK2 signaling [12–15].